Literature DB >> 33717024

Evaluation of the Inflammatory Cytokines and IL-10 Network in Individuals Co-infected With Human T-Cell Lymphotropic Virus and Hepatitis C Virus (HTLV/HCV).

Felicidade Mota Pereira1,2, Pablo Ivan Pereira Ramos3, Monique Lirio1, Ajax Mercês Atta4, Isabela Silva de Oliveira4, Fabio Carneiro Vosqui Nascimento5, Marcelo Costa Silva6, Bernardo Galvão-Castro7, Maria Fernanda Rios Grassi1,7.   

Abstract

BACKGROUND: Co-infection between the human T-cell lymphotropic virus (HTLV) and the hepatitis C virus (HCV) can modify the natural history of HCV infection. The aim of this study was to describe the inflammatory cytokines and IL-10 network in patients co-infected with HTLV and HCV viruses in Bahia, Brazil.
METHODS: Samples from 31 HTLV/HCV co-infected individuals and 27 HCV monoinfected individuals were evaluated. IFN-γ, TNF-α, IL-10, IL-8, and IL-1 cytokines were quantified by ELISA. Clinical, laboratory data were obtained from patient records. Serum levels of the cytokines were log10-transformed and data mining was performed using Z-score statistics and correlation analysis.
RESULTS: Co-infected individuals presented a tendency toward higher production of INF-γ compared to the HCV monoinfected group. Regarding cytokine pairs, there was a positive correlation (P-value < 0.05) between IL-1 and IL-8 in the HTLV/HCV co-infected group and uninfected controls, and two correlations in the HCV mono-infected group IL-8 - IL10 and IL- INF-γ - IL-10 pairs. There was no significant difference between the groups for the other parameters analyzed.
CONCLUSION: The results presented herein indicated that HTLV/HCV co-infection was associated with a trend in IFN-γ production while HCV-infected individuals presented a positive correlation with both inflammatory cytokines (IL-8 and IFN-γ) and the regulatory cytokine IL-10.
Copyright © 2021 Pereira, Ramos, Lirio, Mercês Atta, Silva de Oliveira, Nascimento, Silva, Galvão-Castro and Rios Grassi.

Entities:  

Keywords:  HCV; HTLV; co-infection; cytokines; network

Year:  2021        PMID: 33717024      PMCID: PMC7953037          DOI: 10.3389/fmicb.2021.632695

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  28 in total

1.  An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group.

Authors:  P Bedossa; T Poynard
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

2.  Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.

Authors:  María Abad-Fernández; Ana Moreno; Fernando Dronda; Santos del Campo; Carmen Quereda; José Luis Casado; María-Jesús Pérez-Elías; Santiago Moreno; Alejandro Vallejo
Journal:  AIDS       Date:  2015-02-20       Impact factor: 4.177

3.  Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomes.

Authors:  Otávio M Espíndola; Alexandre G Vizzoni; Elisabeth Lampe; Maria José Andrada-Serpa; Abelardo Q C Araújo; Ana Claudia C Leite
Journal:  Int J Infect Dis       Date:  2017-02-07       Impact factor: 3.623

4.  Cohort study of hepatotropic virus and human T lymphotropic virus type-I infections in an area endemic for adult T cell leukemia.

Authors:  S Kamihira; S Momita; S Ikeda; Y Yamada; H Sohda; S Atogami; M Tomonaga; K Kinoshita; K Toriya; R Furukawa
Journal:  Jpn J Med       Date:  1991 Nov-Dec

5.  HTLV-2 infection in injection drug users in King County, Washington.

Authors:  Joseph R Zunt; Ken Tapia; Hanne Thiede; Rong Lee; Holly Hagan
Journal:  Scand J Infect Dis       Date:  2006

6.  Assessment of pro-inflammatory cytokines in sera of patients with hepatitis C virus infection before and after anti-viral therapy.

Authors:  Abdulkarim Alhetheel; Ahmed Albarrag; Zahid Shakoor; Khalid Alswat; Ayman Abdo; Waleed Al-Hamoudi
Journal:  J Infect Dev Ctries       Date:  2016-10-31       Impact factor: 0.968

7.  High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  D C B L Aroucha; R F do Carmo; P Moura; J L A Silva; L R S Vasconcelos; M S M Cavalcanti; M T C Muniz; M L Aroucha; E R F Siqueira; G G O M Cahú; L M M B Pereira; M R C D Coêlho
Journal:  Cytokine       Date:  2013-04-16       Impact factor: 3.861

8.  HCV/HTLV coinfection: Does HTLV-1 interfere in the natural history of HCV-related diseases?

Authors:  Marcelo Costa Silva; Carolina Alves Costa Silva; Gustavo Uzêda Machado; Ajax Atta; Songeli M Freire; Edgar Carvalho; Maria Isabel Schinoni; Raymundo Paraná
Journal:  J Med Virol       Date:  2016-04-22       Impact factor: 2.327

9.  Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: a proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10.

Authors:  Soriane de Souza-Cruz; Marilú Barbieri Victória; Andréa Monteiro Tarragô; Allyson Guimarães da Costa; João Paulo Diniz Pimentel; Ericka Florêncio Pires; Lorene de Paula Araújo; Jordana Grazziela Coelho-dos-Reis; Matheus de Souza Gomes; Laurence Rodrigues Amaral; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Flamir da Silva Victória; Adriana Malheiro
Journal:  BMC Microbiol       Date:  2016-01-07       Impact factor: 3.605

10.  Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1.

Authors:  Marcia Moreira; André Ramos; Eduardo M Netto; Carlos Brites
Journal:  Braz J Infect Dis       Date:  2013-09-09       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.